Santosa Sylvia, Demonty Isabelle, Lichtenstein Alice H, Ordovas Jose M, Jones Peter J H
School of Dietetics and Human Nutrition, McGill University, Ste-Anne-de-Bellevue, Québec, Canada.
J Lipid Res. 2007 Dec;48(12):2607-13. doi: 10.1194/jlr.M600452-JLR200. Epub 2007 Sep 7.
The purpose of this study was to examine whether changes in cholesterol metabolism after weight loss were affected by single nucleotide polymorphisms (SNPs) in ABCG5 and ABCG8 genes. Thirty-five hypercholesterolemic women lost 11.7 +/- 2.5 kg (P < 0.001). Cholesterol kinetics were assessed using stable isotope techniques. TaqMan PCR was used to detect SNPs in ABCG5/G8. Homozygous Q604E variants in ABCG5 had larger (P < 0.05) reductions in cholesterol absorption and greater increases (P < 0.05) in synthesis in contrast to heterozygous and homozygous wild-type carriers. Heterozygous C54Y carriers had smaller declines (P = 0.047) in synthesis compared with homozygous variant individuals. The presence of at least one Y54 variant was associated with higher (P = 0.042) post-weight-loss synthesis compared with carriers of the C54 genotype. The direction of the results is consistent with cross-sectional studies on the effects of Q604E and C54Y polymorphisms on plasma cholesterol. SNPs in ABCG5/G8 were found to be associated with the response of cholesterol metabolism to weight loss. The evidence for associations between SNPs in ABCG5/G8 and various parameters of cholesterol metabolism indicates the potential effectiveness of establishing genetic screening tools to determine optimal lipid-lowering treatment routes for individuals during weight reduction.
本研究的目的是检验体重减轻后胆固醇代谢的变化是否受ABCG5和ABCG8基因单核苷酸多态性(SNP)的影响。35名高胆固醇血症女性体重减轻了11.7±2.5千克(P<0.001)。使用稳定同位素技术评估胆固醇动力学。采用TaqMan PCR检测ABCG5/G8中的SNP。与杂合子和纯合野生型携带者相比,ABCG5中纯合Q604E变体的胆固醇吸收降低幅度更大(P<0.05),合成增加幅度更大(P<0.05)。与纯合变体个体相比,杂合子C54Y携带者的合成下降幅度较小(P = 0.047)。与C54基因型携带者相比,至少存在一个Y54变体与体重减轻后的合成较高(P = 0.042)有关。结果的方向与关于Q604E和C54Y多态性对血浆胆固醇影响的横断面研究一致。发现ABCG5/G8中的SNP与胆固醇代谢对体重减轻的反应有关。ABCG5/G8中SNP与胆固醇代谢各种参数之间关联的证据表明,建立基因筛查工具以确定个体在减重期间的最佳降脂治疗途径具有潜在有效性。